Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)

v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Mar. 31, 2024 $ 203,209 $ (194,349) $ (2,723) $ 6,137
Beginning balance, shares at Mar. 31, 2024 780,371        
Proceeds from At-the-Market sale of common stock, net of offering expenses 748 748
Proceeds from At-the-Market sale of common stock, net of offering expenses, shares 158,311        
Exercise of employee stock options 7 7
Exercise of employee stock options, shares 2,000        
Employee stock-based compensation 107 107
Employee stock-based compensation, shares 9,538        
Foreign currency translation adjustment (881) (881)
Net loss (1,143) (1,143)
Ending balance, value at Jun. 30, 2024 204,071 (195,492) (3,604) 4,975
Ending balance, shares at Jun. 30, 2024 950,220        
Beginning balance, value at Mar. 31, 2024 203,209 (194,349) (2,723) 6,137
Beginning balance, shares at Mar. 31, 2024 780,371        
Net loss         (2,681)
Ending balance, value at Dec. 31, 2024 206,454 (197,030) (4,554) 4,870
Ending balance, shares at Dec. 31, 2024 1,615,765        
Beginning balance, value at Jun. 30, 2024 204,071 (195,492) (3,604) 4,975
Beginning balance, shares at Jun. 30, 2024 950,220        
Proceeds from At-the-Market sale of common stock, net of offering expenses 1,541 1,541
Proceeds from At-the-Market sale of common stock, net of offering expenses, shares 381,433        
Exercise of employee stock options 26 26
Exercise of employee stock options, shares 7,250        
Payments for fractional shares related to reverse-split (1) (1)
Payments for fractional shares related to reverse-split, shares (288)        
Employee stock-based compensation 14 14
Foreign currency translation adjustment (593) (593)
Net loss (610) (610)
Ending balance, value at Sep. 30, 2024 205,651 (196,102) (4,197) 5,352
Ending balance, shares at Sep. 30, 2024 1,338,615        
Proceeds from At-the-Market sale of common stock, net of offering expenses 790 790
Proceeds from At-the-Market sale of common stock, net of offering expenses, shares 277,150        
Employee stock-based compensation 13 13
Foreign currency translation adjustment (357) (357)
Net loss (928) (928)
Ending balance, value at Dec. 31, 2024 206,454 (197,030) (4,554) 4,870
Ending balance, shares at Dec. 31, 2024 1,615,765        
Beginning balance, value at Mar. 31, 2025 206,593 (197,806) (4,376) 4,411
Beginning balance, shares at Mar. 31, 2025 1,634,265        
Exercise of employee stock options 23 23
Exercise of employee stock options, shares 8,500        
Employee stock-based compensation 57 57
Foreign currency translation adjustment 806 806
Net loss (1,241) (1,241)
Ending balance, value at Jun. 30, 2025 206,673 (199,047) (3,570) 4,056
Ending balance, shares at Jun. 30, 2025 1,642,765        
Beginning balance, value at Mar. 31, 2025 206,593 (197,806) (4,376) 4,411
Beginning balance, shares at Mar. 31, 2025 1,634,265        
Net loss         (2,594)
Ending balance, value at Dec. 31, 2025 207,023 (200,400) (3,191) 3,432
Ending balance, shares at Dec. 31, 2025 1,730,613        
Beginning balance, value at Jun. 30, 2025 206,673 (199,047) (3,570) 4,056
Beginning balance, shares at Jun. 30, 2025 1,642,765        
Exercise of employee stock options 21 21
Exercise of employee stock options, shares 7,000        
Employee stock-based compensation 39 39
Foreign currency translation adjustment 205 205
Net loss (534) (534)
Ending balance, value at Sep. 30, 2025 206,733 (199,581) (3,365) 3,787
Ending balance, shares at Sep. 30, 2025 1,649,765        
Proceeds from At-the-Market sale of common stock, net of offering expenses 266 266
Proceeds from At-the-Market sale of common stock, net of offering expenses, shares 80,848        
Employee stock-based compensation 24 24
Foreign currency translation adjustment 174 174
Net loss (819) (819)
Ending balance, value at Dec. 31, 2025 $ 207,023 $ (200,400) $ (3,191) $ 3,432
Ending balance, shares at Dec. 31, 2025 1,730,613